Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1.

Ellen Heitzer; Monika Artl; Martin Filipits; Margit Resel; Ricarda Graf; Bettina Weißenbacher; Sigurd Lax; Michael Gnant; Fritz Wrba; Richard Greil; Otto Dietze; Friedrich Hofbauer; Gerhard Böhm; Gerald Höfler; Hellmut Samonigg; Renate Schaberl-Moser; Marija Balic; Nadia Dandachi

doi:10.1038/modpathol.2013.204

Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1.

Ellen Heitzer, Monika Artl, Martin Filipits, Margit Resel, Ricarda Graf, Bettina Weißenbacher, Sigurd Lax, Michael Gnant, Fritz Wrba, Richard Greil (Co-author), Otto Dietze (Co-author), Friedrich Hofbauer, Gerhard Böhm, Gerald Höfler, Hellmut Samonigg, Renate Schaberl-Moser, Marija Balic, Nadia Dandachi

Institute of Pathology
Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

21 Citations (Web of Science)

Original language	English
Pages (from-to)	906-915
Journal	MODERN PATHOLOGY
Volume	27
Issue number	6
DOIs	https://doi.org/10.1038/modpathol.2013.204
Publication status	Published - 2014

Keywords

NORMAL COLONIC-MUCOSA
MICROSATELLITE INSTABILITY
DNA METHYLATION
ADJUVANT CHEMOTHERAPY
BRAF MUTATION
TUMOR
EXPRESSION
PHENOTYPE
HYPERMETHYLATION
5-FLUOROURACIL

Access to Document

10.1038/modpathol.2013.204

Cite this

Heitzer, E., Artl, M., Filipits, M., Resel, M., Graf, R., Weißenbacher, B., Lax, S., Gnant, M., Wrba, F., Greil, R., Dietze, O., Hofbauer, F., Böhm, G., Höfler, G., Samonigg, H., Schaberl-Moser, R., Balic, M., & Dandachi, N. (2014). Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1. MODERN PATHOLOGY , 27(6), 906-915. https://doi.org/10.1038/modpathol.2013.204

Heitzer, Ellen ; Artl, Monika ; Filipits, Martin et al. / Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1. In: MODERN PATHOLOGY 2014 ; Vol. 27, No. 6. pp. 906-915.

@article{20fce6aac392429a94db04e9c29741cb,

title = "Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1.",

keywords = "NORMAL COLONIC-MUCOSA, MICROSATELLITE INSTABILITY, DNA METHYLATION, ADJUVANT CHEMOTHERAPY, BRAF MUTATION, TUMOR, EXPRESSION, PHENOTYPE, HYPERMETHYLATION, 5-FLUOROURACIL",

author = "Ellen Heitzer and Monika Artl and Martin Filipits and Margit Resel and Ricarda Graf and Bettina Wei{\ss}enbacher and Sigurd Lax and Michael Gnant and Fritz Wrba and Richard Greil and Otto Dietze and Friedrich Hofbauer and Gerhard B{\"o}hm and Gerald H{\"o}fler and Hellmut Samonigg and Renate Schaberl-Moser and Marija Balic and Nadia Dandachi",

note = "Third Medical Department, Paracelsus Private Medical University, Salzburg, Austria; Department of Pathology, Paracelsus Private Medical University, Salzburg, Austria",

year = "2014",

doi = "10.1038/modpathol.2013.204",

language = "English",

volume = "27",

pages = "906--915",

journal = "MODERN PATHOLOGY ",

issn = "0893-3952",

number = "6",

}

Heitzer, E, Artl, M, Filipits, M, Resel, M, Graf, R, Weißenbacher, B, Lax, S, Gnant, M, Wrba, F, Greil, R, Dietze, O, Hofbauer, F, Böhm, G, Höfler, G, Samonigg, H, Schaberl-Moser, R, Balic, M & Dandachi, N 2014, 'Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1.', MODERN PATHOLOGY , vol. 27, no. 6, pp. 906-915. https://doi.org/10.1038/modpathol.2013.204

Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1. / Heitzer, Ellen; Artl, Monika; Filipits, Martin et al.
In: MODERN PATHOLOGY , Vol. 27, No. 6, 2014, p. 906-915.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1.

AU - Heitzer, Ellen

AU - Artl, Monika

AU - Filipits, Martin

AU - Resel, Margit

AU - Graf, Ricarda

AU - Weißenbacher, Bettina

AU - Lax, Sigurd

AU - Gnant, Michael

AU - Wrba, Fritz

AU - Greil, Richard

AU - Dietze, Otto

AU - Hofbauer, Friedrich

AU - Böhm, Gerhard

AU - Höfler, Gerald

AU - Samonigg, Hellmut

AU - Schaberl-Moser, Renate

AU - Balic, Marija

AU - Dandachi, Nadia

N1 - Third Medical Department, Paracelsus Private Medical University, Salzburg, Austria; Department of Pathology, Paracelsus Private Medical University, Salzburg, Austria

PY - 2014

Y1 - 2014

KW - NORMAL COLONIC-MUCOSA

KW - MICROSATELLITE INSTABILITY

KW - DNA METHYLATION

KW - ADJUVANT CHEMOTHERAPY

KW - BRAF MUTATION

KW - TUMOR

KW - EXPRESSION

KW - PHENOTYPE

KW - HYPERMETHYLATION

KW - 5-FLUOROURACIL

U2 - 10.1038/modpathol.2013.204

DO - 10.1038/modpathol.2013.204

M3 - Original Article

C2 - 24309322

SN - 0893-3952

VL - 27

SP - 906

EP - 915

JO - MODERN PATHOLOGY

JF - MODERN PATHOLOGY

IS - 6

ER -

Heitzer E, Artl M, Filipits M, Resel M, Graf R, Weißenbacher B et al. Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1. MODERN PATHOLOGY . 2014;27(6):906-915. doi: 10.1038/modpathol.2013.204